AI in Healthcare: A Complex Landscape
Unlike Big Finance (33rd edition) and Big Pharma (34th edition), healthcare is a uniquely complex industry, shaped by an intricate interplay of stakeholders and structural challenges:
Despite these barriers, AI in healthcare is beginning to drive new patient experiences, outcomes, and value.
AI-First Innovators in Healthcare
Without being exhaustive, here are six AI-driven healthcare innovators creating meaningful impact:
1. Zipline – Drone Delivery of Critical Medical Supplies
Zipline is transforming healthcare logistics with the world’s first drone delivery network dedicated to medical supplies. They operate primarily in Africa but also expanded in the U.S., delivering critical medical products like blood, vaccines, and medications to remote or hard-to-reach areas, significantly reducing delivery times from hours to just minutes.
Their drones leverage AI for sophisticated route optimization, ensuring the quickest and most energy-efficient flight paths. Their AI also includes demand forecasting to anticipate medical supply needs, allowing for proactive inventory management.
Zipline has completed over 600 daily flights, serving more than 12 million people, and has a valuation of $1.2 billion. A peer-reviewed study highlighted that their service led to a 40% reduction in maternal mortality due to timely emergency blood deliveries in Rwanda. They’ve also been recognized with awards like the Fast Company’s Innovation by Design and have partnerships with major health organizations, demonstrating their impact and scalability.
2. Woebot Health – AI-Driven Mental Health
Woebot Health is pioneering AI-driven mental health support with its chatbot that provides cognitive behavioral therapy (CBT) and dialectical behavior therapy (DBT) techniques. Available 24/7, Woebot aims to bridge the gap in mental health services, especially in areas with limited access to therapists.
Woebot uses AI to conduct natural language processing for understanding user inputs and delivering personalized therapeutic responses. The AI follows a rule-based CBT rather than generative AI, ensuring consistent and evidence-based therapy. It also uses machine learning to adapt responses based on user interactions, enhancing the therapy experience over time.
With over 2 million users, Woebot has shown through clinical trials reported in JAMA that it can achieve 22% faster depression remission compared to traditional human therapy. They’ve garnered a MedTech Breakthrough Award and have a significant impact on accessibility to mental health care. Revenue specifics are not public, but their user base and clinical outcomes suggest a growing market presence.
3. Biofourmis – AI Chronic Disease Management
Biofourmis specializes in AI-enhanced remote patient monitoring (RPM) for chronic disease management, particularly targeting conditions like heart failure. Their solution integrates wearables with a platform that offers personalized health management and drug optimization.
Biofourmis employs AI algorithms to predict health deterioration, such as heart failure, up to 14 days in advance with 91% accuracy. The AI analyzes data from wearables to provide insights, triggering interventions before symptoms become critical. This proactive approach includes personalized medication adjustments based on real-time health data.
Biofourmis has reduced hospital readmissions by 38% in Medicare patients, leading to savings of around $12,000 per patient. With a valuation of $1.5 billion, they’ve formed partnerships with over 30 health systems. They’ve been recognized with awards like the Frost & Sullivan Technology Innovation Leadership Award, underscoring their success in scaling AI-driven healthcare solutions.
4. Johns Hopkins Sepsis AI – Sepsis Management (Provider Innovation)
Developed by Johns Hopkins, this AI system focuses on early detection and management of sepsis within hospitals. Sepsis, a life-threatening condition, can be particularly deadly if not caught early, making this AI tool vital for reducing mortality rates in acute care settings.
The AI system integrates with electronic health records (EHRs) to analyze real-time patient data, identifying subtle signs of sepsis that might be overlooked by human clinicians. It uses machine learning to continuously refine its detection algorithms based on outcomes and data from multiple hospitals.
The AI has been implemented across 12 hospitals, showing an 18% reduction in sepsis mortality rates, with each patient potentially saving $12,000 in treatment costs. This has been validated through peer-reviewed research, including in JAMA, emphasizing its effectiveness. While exact revenue figures aren’t public, the impact on patient outcomes and hospital costs underscores its success.
5. Proprio Vision- AI Impacts Spinal Surgery
Proprio Vision is transforming spinal surgery with AI-enhanced augmented reality (AR) navigation, aiming to make surgeries more precise and less invasive, reducing complications and radiation exposure.
Their AI system overlays real-time 3D models of the patient’s anatomy onto the surgical field, guiding surgeons with unprecedented accuracy. The AI processes imaging data to predict and adjust for movement, ensuring the surgical tools align perfectly with the intended path.
Proprio Vision has reduced spinal fusion complications by 29% and decreased intraoperative X-rays by a factor of 10. Despite the high setup cost of over $2 million, it’s used in 8% of U.S. hospitals, suggesting strong market acceptance. The potential for $40 billion in annual savings in orthopedic surgeries highlights its economic impact. They’ve won accolades like the MedTech Breakthrough Award for Surgical Navigation.
6. CarePredict- AI for Eldercare
CarePredict focuses on improving the lives of the elderly through AI-powered wearables that monitor daily activities to predict health risks, like falls or cognitive decline, thereby enhancing independent living and reducing healthcare costs.
Their AI wearable, Tempo, uses machine learning to learn individual behavior patterns and detect anomalies that might indicate health issues. It collects data on movement, sleep, and social interactions, using these insights to predict and alert on potential health events before they become emergencies.
CarePredict has shown a 69% reduction in senior falls and a 40% decrease in hospitalizations in studies published in JMIR Aging. Although specific revenue data isn’t available, their impact is recognized through awards like the CES Innovation Award and the CTA Foundation’s Accessibility Contest. Their solution addresses the growing challenge of elder care with a diminishing workforce, showcasing their success in a crucial healthcare segment.
Lessons in Smartness and Need for Coalition Building
Every company and initiative adopting AI faces a unique set of challenges and yet two traits smartness and tenacity standout in their problem solving and persistence.
Other Learnings
Healthcare’s AI ecosystem is more fragmented and adversarial than pharma’s, requiring coalition-building across competing stakeholders. While pharma-style R&D partnerships exist (e.g., Biofourmis-Mayo), success demands navigating a labyrinth of payors, regulators, and legacy tech – making healthcare AI a team sport with no solo winners.
Impact of AI : Beyond Shareholder Value to Larger Public Health
The public health impact of AI extends beyond business goals:
While there is heartening impact from innovators – Zipline (access inequity), Biofourmis (cardio) and players like Lark, Loom (diabetes) chronic disease management and CarePredict(elder care) we are far away from impactful AI for Next Gen Heathcare which is preventive with self and community driven support for longer and healthier lives.
Despite promising AI solutions, we remain far from achieving Next-Gen Healthcare, which should be preventive, self-driven, and community-supported.
Ideas like Florence AI for preventive care (22nd edition), Looking Glass for informed treatment (23rd edition) and Rawls Maximin AI (24th and 25th editions) to unburden medical debt and universal health coverage remain ideas.
But it is good to hope and we have much forward to look forward to.
Takeaways
The 2025 McKinsey research notes that f 92% of companies plan to increase their investment in the next 3 years but also expect that AI should deliver more than 5% revenue growth .Today only 20% achieve that and this is where AI led Accelerated Innovation (AI for AI) matters.
AI tech and infrastructure is constantly and rapidly evolving in its capabilities and support super agency to deliver revenue and strategic value.
Being efficient is one and being disruptive is another. Both are paths to pursue.
However to do the disruptive, the key questions you should ask/continue to ask are:
PS: As we pointed the public health impact of AI as you explore the potential of AI in your own industry, also consider how it can contribute to improving lives and creating a more equitable future for all. By aligning business goals with societal needs, we can unlock the full potential of AI for social good.
II. Questioning / Asking
Good conversations flow from well‑sequenced questions—topical, simple, coherent, cohesive.
LLM Conversation Example 1
Q: What are empirical judgments?
A: Empirical judgments are based on observation, experience, or experimentation.
Q: What are moral judgments?
A: Moral judgments are based on ethical principles and values.
